<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Research & Development News</title> 
<link>http://www.mdlinx.com/pharma-news/news.cfm/newspage/1/spec_id/39/subspec_id/715</link> 
<description>Research & Development</description> 
<language>en-us</language> 
<copyright>Copyright 2013 MDLinx, Inc.</copyright>



<item> 
<title><![CDATA[Par pharmaceutical begins shipment of generic atacand]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4639503/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>Par Pharmaceutical</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4639503/?xml</guid>
</item> 

<item> 
<title><![CDATA[Pfizer Announces Plan for Split-Off of Zoetis]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4639139/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>Pfizer</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4639139/?xml</guid>
</item> 

<item> 
<title><![CDATA[Making the medical home more homey]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4618545/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>Health Data Management</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4618545/?xml</guid>
</item> 

<item> 
<title><![CDATA[Community health centers to AID in HIX enrollment]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4618542/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>Health Data Management</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4618542/?xml</guid>
</item> 

<item> 
<title><![CDATA[Quintiles rated industry leader and highest in service quality in phase II/III clinical research]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4636904/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>Quintiles Transnational</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4636904/?xml</guid>
</item> 

<item> 
<title><![CDATA[Merck statement on fda advisory committee meeting for suvorexant]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4639138/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>Merck</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4639138/?xml</guid>
</item> 

<item> 
<title><![CDATA[Modern family star julie bowen calls on communities to raise their hand for anaphylaxis awareness in nationwide competition]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4639504/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>Mylan</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4639504/?xml</guid>
</item> 

<item> 
<title><![CDATA[Bristol-myers squibb advances leadership position in immuno-oncology with data to be presented at 2013 American Society of Clinical Oncology (asco) Annual Meeting]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4633609/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>Bristol Myers-Squibb</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4633609/?xml</guid>
</item> 

<item> 
<title><![CDATA[Bristol-myers squibb announces intention to voluntarily delist preferred stock]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4633607/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>Bristol Myers-Squibb</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4633607/?xml</guid>
</item> 

<item> 
<title><![CDATA[Elan&#39;s response to royalty pharma announcement]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4633917/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>Elan</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4633917/?xml</guid>
</item> 

<item> 
<title><![CDATA[New study shows effect of neupro (rotigotine transdermal system) on cardiovascular measures in patients with restless legs syndrome]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4630509/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>UCB</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4630509/?xml</guid>
</item> 

<item> 
<title><![CDATA[Agenus announces initiation of enrollment in nci-sponsored randomized trial of prophage g-200 vaccine with avastin in treatment of brain tumors]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4639163/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>Agenus</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4639163/?xml</guid>
</item> 

<item> 
<title><![CDATA[Patheon announces changes to its commercial operations structure]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4636565/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>Patheon</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4636565/?xml</guid>
</item> 

<item> 
<title><![CDATA[NPS pharmaceuticals recognized by national organization for rare disorders for gattex as an innovative treatment for patients with short bowel syndrome]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4625298/?xml</link> 
<pubDate>5/23/2013</pubDate> 
<description><![CDATA[<b>NPS Pharmaceuticals</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4625298/?xml</guid>
</item> 
  


</channel> 
</rss>

